Eli Lilly says GLP-1 pill for diabetes and weight loss effective in study, plans to seek FDA approval
CBSN
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for diabetes and weight loss.
The trial of the drug, orforglipron, measured its efficacy and safety in adults with Type 2 diabetes compared to a placebo. It found the pill lowered A1C, a blood level used to diagnose diabetes, by an average of 1.3% to 1.6%, across different doses, after 40 weeks.
Participants taking the highest dose also lost an average of 16 pounds.
Run 3 Space | Play Space Running Game
Traffic Jam 3D | Online Racing Game
Duck Hunt | Play Old Classic Game
Washington — Health and Human Services Secretary Robert F. Kennedy Jr. on Monday said he is removing every member of a government panel that makes vaccine recommendations.
A dazzling image taken by NASA's 2001 Mars Odyssey orbiter shows an unprecedented view of a 12-mile-high volcano poking through clouds at dawn on the Red Planet.
Merryl Hoffman knew she was taking good care of her heart. The 63-year-old attorney didn't smoke or drink, and she was an avid hiker who used to run marathons and other distance races. In her 40s, she had been diagnosed with a leaky mitral valve and underwent surgery to repair it. Every year since, she has seen a cardiologist to check her heart and its function. The reports always came back clear.
A Texas woman died from an infection caused by a brain-eating amoeba after using tap water in a nasal irrigation device, according to the Centers for Disease Control and Prevention.
A private lunar lander from Japan is closing in on the moon, aiming for a touchdown in the unexplored far north with a mini rover.
Esther Bejarano's son was 11 months old when asthma landed him in the hospital. She didn't know what had triggered his symptoms — neither she nor her husband had asthma — but she suspected it was the pesticides sprayed on the agricultural fields near her family's home.
FDA to "review the latest data" on mifepristone. What could it mean for access to the abortion pill?
Health and Human Services Secretary Robert F. Kennedy Jr. has asked Food and Drug Administration Commissioner Marty Makary "to review the latest data on mifepristone," raising questions about the drug commonly referred to as the abortion pill.
Scientists have unlocked one of the solar system's many secrets from an unexpected source: a planetarium show.
A Centers for Disease Control and Prevention official said Tuesday she was resigning from her role overseeing updates to the agency's COVID-19 vaccine recommendations, following an order by Health and Human Services Secretary Robert F. Kennedy Jr. to force an update to the agency's guidance.
The active ingredient in Pepto Bismol, bismuth subsalicylate, is often used to treat and prevent diarrhea while traveling — but a new study found it may not help with prevention.
Amid a widespread decline in childhood measles vaccination rates since before the COVID-19 pandemic across the United States, a study published Monday found that coverage can vary substantially within a state.
New research suggests that removing fluoride from public water would increase dental care costs and tooth decay for children across the United States.
Colon cancer patients saw improved survival rates after a 3-year exercise program, according to a first-of-its-kind international experiment.